Today, AARP launched an e-card campaign aimed at moms with adult children, offering a unique way to encourage young adults to purchase health insurance. Recognizing that 8.6 million young adults age 26-34 are uninsured, AARP is encouraging their moms – many of whom are our members – to remind their kids to sign up for insurance as required by the Affordable Care Act.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63237-aarp-e-card-campaign-young-adults-mom-means-it-get-health-insurance
Land of Lincoln Health™, the first and only consumer operated and oriented health insurance plan (CO-OP) in Illinois, is offering 35 health insurance plans on the State of Illinois’ health insurance marketplace, Get Covered Illinois. Land of Lincoln Health is a non-profit health insurance company with the primary focus of improving services for its members.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63573-land-of-lincoln-health-insurance-plan-co-op-get-covered-illinois
More than 20 million Americans are currently affected by cataracts, and a new survey from AARP Media Sales and Alcon, the global leader in eye care, found that there are many questions and misperceptions among baby boomers about the condition, their options and how to treat it.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63529-alcon-and-a-a-r-p-mark-world-sight-day-first-live-cataract-education-event
ADP®, a leading global provider of Human Capital Management (HCM) solutions, today announced further enhancements to its TotalSource® solution to help small and midsized businesses manage compliance and avoid penalties associated with the Affordable Care Act (ACA). Since TotalSource’s initial release of the dashboard in February 2013, ADP has continued to refine and enhance the solution as additional ACA information and guidance has become available.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64458-adp-helps-businesses-manage-aca-compliance-and-avoid-penalties
Today Enroll America partnered with the Ad Council to launch “Take Care, People,” a national multimedia public service advertising (PSA) campaign that will raise awareness, educate, and motivate uninsured Americans to get health insurance for themselves and their families under the Affordable Care Act, or ACA.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65436-enroll-america-ad-council-encourage-uninsured-sign-up-affordable-care-act
Walgreens (NYSE:WAG)(Nasdaq:WAG) announces the launch of the 2014 Walgreens Way to Well Health Tour with AARP. For six years, Walgreens and AARP have conducted the community outreach program dedicated to providing free preventive and early detection health services to communities across the country. Now through December, Walgreens will use the tour to provide free health tests, assessments, education and consulting services with a renewed commitment to the everyday health of Americans nationwide.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7158751-walgreens-2014-way-to-well-health-tour-aarp
Global health service company Cigna is putting a healthy spin on the popular social behavior of taking food selfies and sharing them with friends. Now your healthy snack can reap more than “likes” -- with a chance to win a grand prize of a healthy cooking retreat for the winner and their guest with the Conscious Gourmet; 1-on-1 sessions with a Cigna nutritionist for a year and a smartphone with pre-loaded Cigna healthy apps, to name a few.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7185731-cigna-your-healthy-you-food-contest-go-you/
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
The Preeclampsia Foundation, the nation’s only non-profit patient advocacy organization for preeclampsia and related hypertensive disorders of pregnancy, today announced the results of a recent nationwide Preeclampsia Awareness Survey of more than 1,500 expectant and new mothers. These findings are driving the Foundation’s strategies associated with National Preeclampsia Awareness Month.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7171451-preeclampsia-foundation-awareness-survey-education-pregnancy-disorders
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. While several leading cancer centers have only begun introducing immunotherapy, Issels has been a leader in Integrative Immunotherapy for decades.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7224051-issels-integrative-immunotherapy-lung-cancer-advanced-treatment
